Scientists track experimental drug's journey through the body

NCT ID NCT07463053

Not yet recruiting Knowledge-focused Sponsor: Jemincare Source: ClinicalTrials.gov ↗

Summary

This early study aims to understand how the body absorbs, processes, and eliminates an experimental drug called JMKX003142. It will involve 8 healthy male volunteers. Researchers will track how much of the drug gets into the bloodstream and how it leaves the body to help design future studies for polycystic kidney disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADPKD (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

Explore the condition pages connected to this study.